Comparison of Retinal Perfusion Between Diabetic and Non-diabetic Patients With OCT Angiography After Cataract Surgery.

Sponsor
Peking University Third Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03903965
Collaborator
(none)
120
1
33
3.6

Study Details

Study Description

Brief Summary

This study aims to compare the retinal perfusion between diabetic and non-diabetic patients with Optical Coherence Tomography(OCT) Angiography after cataract surgery, to thoroughly evaluate the retinal state of diabetics after surgery, and to find out the relationship between postoperative complications occurred in retina and diabetes.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    In this study, we perform a completely comparison of retina state characteristic including the foveal avascular zone(FAZ),perifovea vessel density,parafovea vessel density,macular thickness,perifovea thickness,parafovea thickness in superficial and deep layers of retina with OCT Angiography after cataract surgery,and analysis on the differences of EGF,IFN-γ,IL-10,IL-12,IL-1β,IL-6,IL-8,IP-10,MCP-1,VEGF in aqueous humor before surgery between diabetic and non-diabetic patients and to explore the potential correlations between postoperative complications occurred in retina and diabetes.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    120 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Comparison of Retinal Perfusion Between Diabetic and Non-diabetic Patients With OCT Angiography After Cataract Surgery.
    Actual Study Start Date :
    Sep 1, 2018
    Actual Primary Completion Date :
    Dec 1, 2020
    Actual Study Completion Date :
    Jun 1, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    diabetic patients after cataract surgery

    diabetic patients after cataract surgery

    non-diabetic patients after cataract surgery

    non-diabetic patients after cataract surgery

    Outcome Measures

    Primary Outcome Measures

    1. OCT Angiography parameters [3 months postoperatively]

      comparison of vessel density in superficial and deep layers of retina between diabetic and non-diabetic patients with OCT Angiography.

    Secondary Outcome Measures

    1. aqueous humor cytokines levels [intraoperatively.]

      comparison the levels of cytokines from aqueous humor including EGF,IFN-γ,IL-10,IL-12,IL-1β,IL-6,IL-8,IP-10,MCP-1,VEGF between diabetic and non-diabetic patients.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Patients with age-related cataract and with willing to improve visual acuity by undergoing phacoemulsification and intraocular lens implantation surgery.

    2. Type 2 diabetes diagnosis according to American Diabetes Association# Standards of Medical Care in Diabetes -2017(ADA, American Diabetes Association)

    3. Willing to sign the consent form.

    Exclusion Criteria:
    1. having known maculopathy, proliferative diabetic retinopathy(PDR), diabetic macular edema.

    2. with high myopia of spherical equivalent greater than -6.0 diopters or axial length (AXL) greater than 26 mm in either eye.

    3. preexisting vein or artery occlusion,glaucoma, previous uveitis, a history of ocular trauma, laser treatment, intravitreal injections or intraocular surgeries.

    4. patients who had complications during cataract surgery.

    Elimination Criteria:
    1. poor compliance

    2. voluntary withdrawal

    3. any other kind of situation that researchers consider not suitable for further study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Peking University Third Hospital Beijing Beijing China 100191

    Sponsors and Collaborators

    • Peking University Third Hospital

    Investigators

    • Study Director: Hong Qi, MD, Peking University Third Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hong Qi, Principal Investigator, Peking University Third Hospital
    ClinicalTrials.gov Identifier:
    NCT03903965
    Other Study ID Numbers:
    • 2019032501
    First Posted:
    Apr 4, 2019
    Last Update Posted:
    May 3, 2022
    Last Verified:
    May 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Hong Qi, Principal Investigator, Peking University Third Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 3, 2022